{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T13:33:48Z","timestamp":1768484028381,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.taap.2012.09.003","type":"journal-article","created":{"date-parts":[[2012,9,12]],"date-time":"2012-09-12T18:36:50Z","timestamp":1347475010000},"page":"351-359","source":"Crossref","is-referenced-by-count":8,"title":["The effects of clobazam treatment in rats on the expression of genes and proteins encoding glucronosyltransferase 1A\/2B (UGT1A\/2B) and multidrug resistance\u2010associated protein-2 (MRP2), and development of thyroid follicular cell hypertrophy"],"prefix":"10.1016","volume":"265","author":[{"given":"Izuru","family":"Miyawaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akitoshi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izumi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Inada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kunimatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Funabashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2012.09.003_bb0005","first-page":"173","article-title":"Mechanisms of chemical injury of thyroid gland","volume":"387","author":"Capen","year":"1994","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.taap.2012.09.003_bb0010","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/toxsci\/68.2.372","article-title":"Comparative responsiveness of hypothyroxinemia and hepatic enzyme induction in Long-Evans rats versus C57BL\/6J mice exposed to TCDD-like and phenobarbital-like polychlorinated biphenyl congeners","volume":"68","author":"Craft","year":"2002","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2012.09.003_bb0015","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/toxsci\/66.1.16","article-title":"Increase in bile flow and biliary excretion of glutathione-derived sulfhydryls in rats by drug-metabolizing enzyme inducers is mediated by multidrug resistance protein 2","volume":"66","author":"Johnson","year":"2002","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2012.09.003_bb0020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/019262339001800202","article-title":"Tumor promoting effect of goitrogens on the rat thyroid","volume":"18","author":"Kanno","year":"1990","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.taap.2012.09.003_bb0030","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/toxsci\/kfh225","article-title":"A possible mechanism for decrease in serum thyroxine level by polychlorinated biphenyls in Wistar and Gunn rats","volume":"81","author":"Kato","year":"2004","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2012.09.003_bb0025","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1124\/dmd.109.028621","article-title":"4-Hydroxy-2,2\u2032,3,4\u2032,5,5\u2032,6-heptachlorobiphenyl-mediated decrease in serum thyroxine level in mice occurs through increase in accumulation of thyroxine in the liver","volume":"37","author":"Kato","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2012.09.003_bb0035","first-page":"787","article-title":"Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2","volume":"378","author":"Keppler","year":"1997","journal-title":"Biol. Chem."},{"key":"10.1016\/j.taap.2012.09.003_bb0040","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/toxsci\/kfi074","article-title":"Comparative study of the endocrine-disrupting activity of bisphenol A and 19 related compounds","volume":"84","author":"Kitamura","year":"2005","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2012.09.003_bb0045","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/toxsci\/kfm214","article-title":"Xenobiotic transporters: ascribing function from gene knockout and mutation studies","volume":"101","author":"Klaassen","year":"2008","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2012.09.003_bb0050","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.tox.2007.06.088","article-title":"Effects of a 5-day treatment with the UV-filter octyl-methoxycinnamate (OMC) on the function of the hypothalamo-pituitary-thyroid function in rats","volume":"238","author":"Klammer","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2012.09.003_bb0055","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0009-2797(01)00163-6","article-title":"Pregnane X receptor: molecular basis for species differences in CYP3A induction by xenobiotics","volume":"134","author":"LeCluyse","year":"2001","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.taap.2012.09.003_bb0060","series-title":"Casarett and Doull's Toxicology: The Basic Science of Poisons","first-page":"131","article-title":"Absorption, distribution and excretion of xenobiotics","author":"Lehman-McKeeman","year":"2008"},{"key":"10.1016\/j.taap.2012.09.003_bb0065","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.taap.2004.10.012","article-title":"Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense","volume":"204","author":"Leslie","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2012.09.003_bb0070","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/aps.2011.161","article-title":"A mechanism-based pharmacokinetic\/pharmacodynamic model for CYP3A1\/2 induction by dexamethasone in rats","volume":"33","author":"Li","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.taap.2012.09.003_bb0075","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0022-3565(25)09638-7","article-title":"Alteration of thyroid homeostasis by UDP-glucuronosyltransferase inducers in rats: a dose\u2013response study","volume":"273","author":"Liu","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2012.09.003_bb0080","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1530\/acta.0.0910271","article-title":"Effects of methylmercaptoimidazole (MMI), propylthiouracil (PTU), potassium perchlorate (KClO4) and potassium iodide (KI) on the serum concentrations of thyrotrophin (TSH) and thyroid hormones in the rat","volume":"91","author":"Mannisto","year":"1979","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"10.1016\/j.taap.2012.09.003_bb0085","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0041-008X(89)90004-5","article-title":"The effect of phenobarbital on the metabolism and excretion of thyroxine in rats","volume":"99","author":"McClain","year":"1989","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2012.09.003_bb0090","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1124\/mol.105.011080","article-title":"Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP\/ABCG2) in liver","volume":"67","author":"Merino","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.taap.2012.09.003_bb0095","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.taap.2003.08.001","article-title":"Endocrine disruptors induce cytochrome P450 by affecting transcriptional regulation via pregnane X receptor","volume":"193","author":"Mikamo","year":"2003","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2012.09.003_bb0105","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.toxlet.2003.08.002","article-title":"Mechanism of clobazam-induced thyroidal oncogenesis in male rats","volume":"145","author":"Miyawaki","year":"2003","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.taap.2012.09.003_bb0100","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.yrtph.2011.04.009","article-title":"Toxicological approach for elucidation of clobazam-induced hepatomegaly in male rats","volume":"60","author":"Miyawaki","year":"2011","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.taap.2012.09.003_bb0110","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2133\/dmpk.19.339","article-title":"Eisai hyperbilirubinemic rat (EHBR) as an animal model affording high drug-exposure in toxicity studies on organic anions","volume":"19","author":"Naba","year":"2004","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.taap.2012.09.003_bb0115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1254\/fpj.118.117","article-title":"A pharmacological profile of clobazam (Mystan), a new antiepileptic drug","volume":"118","author":"Nakajima","year":"2001","journal-title":"Nihon Yakurigaku Zasshi"},{"key":"10.1016\/j.taap.2012.09.003_bb0120","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00424-006-0109-y","article-title":"The apical conjugate efflux pump ABCC2 (MRP2)","volume":"453","author":"Nies","year":"2007","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.taap.2012.09.003_bb0125","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00008571-199206000-00001","article-title":"The novel bilirubin\/phenol UDP-glucuronosyltransferase UGT1 gene locus: implications for multiple nonhemolytic familial hyperbilirubinemia phenotypes","volume":"2","author":"Owens","year":"1992","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.taap.2012.09.003_bb0130","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1530\/acta.0.0810495","article-title":"Inhibition of thyroglobulin biosynthesis and degradation by excess iodide. Synergism with lithium","volume":"81","author":"Radvila","year":"1976","journal-title":"Acta Endocrinol. (Copenh.)"},{"issue":"Suppl. 5","key":"10.1016\/j.taap.2012.09.003_bb0135","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1111\/j.1528-1157.1994.tb05978.x","article-title":"Clobazam in the treatment of epilepsy: a review of the literature","volume":"35","author":"Remy","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.taap.2012.09.003_bb0140","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/toxsci\/kfq125","article-title":"Role of UDP-glucuronosyltransferase (UGT) 2B2 in metabolism of triiodothyronine: effect of microsomal enzyme inducers in Sprague Dawley and UGT2B2-deficient Fischer 344 rats","volume":"116","author":"Richardson","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2012.09.003_bb0145","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.toxlet.2008.05.019","article-title":"Mechanism of trifluralin-induced thyroid tumors in rats","volume":"180","author":"Saghir","year":"2008","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.taap.2012.09.003_bb0150","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0016-5085(00)70224-1","article-title":"Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver","volume":"118","author":"Stieger","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2012.09.003_bb0155","first-page":"1273","article-title":"Role of transporters in the detoxication of xenobiotics: recent advances in the Study of cMOAT\/MRP","volume":"42","author":"Suzuki","year":"1997","journal-title":"Protein, Nucleic Acid Enzyme"},{"key":"10.1016\/j.taap.2012.09.003_bb0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/toxsci\/kfn230","article-title":"Effects of perinatal PBDE exposure on hepatic phase I, phase II, phase III, and deiodinase 1 gene expression involved in thyroid hormone metabolism in male rat pups","volume":"107","author":"Szabo","year":"2009","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2012.09.003_bb0165","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0041-008X(86)90194-8","article-title":"Antithyroid effects of propylthiouracil and sulfamonomethoxine in rats and monkeys","volume":"82","author":"Takayama","year":"1986","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2012.09.003_bb0170","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0006-2952(93)90136-K","article-title":"Increased glucuronidation of thyroid hormone in hexachlorobenzene-treated rats","volume":"45","author":"van Raaij","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2012.09.003_bb0175","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1210\/en.2002-220744","article-title":"Anion selectivity by the sodium iodide symporter","volume":"144","author":"Van Sande","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.taap.2012.09.003_bb0180","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1210\/endo.133.5.8404669","article-title":"Glucuronidation of thyroid hormone in rat liver: effects of in vivo treatment with microsomal enzyme inducers and in vitro assay conditions","volume":"133","author":"Visser","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.taap.2012.09.003_bb0185","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1124\/jpet.108.147371","article-title":"Disposition of flavonoids via enteric recycling: UDP-glucuronosyltransferase (UGT) 1As deficiency in Gunn rats is compensated by increases in UGT2Bs activities","volume":"329","author":"Wang","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2012.09.003_bb0190","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00204-010-0613-x","article-title":"Perfluorooctane sulfonate increased hepatic expression of OAPT2 and MRP2 in rats","volume":"85","author":"Yu","year":"2011","journal-title":"Arch. Toxicol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X12003997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X12003997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T10:45:38Z","timestamp":1744109138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X12003997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0041008X12003997"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2012.09.003","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}